eDNA Biotech provides a handheld, battery‑operated nucleic acid amplification device that performs automated sample‑to‑answer bacterial identification and antimicrobial‑resistance profiling at the point of care. The system uses isothermal amplification and built‑in fluorescence detection to deliver laboratory‑grade results in ≤30 minutes, with secure data export for EMR integration. It targets clinics, mobile health units, and public‑health agencies operating in resource‑limited settings.
Funding
$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare providers and field teams often lack access to fast, accurate molecular diagnostics because conventional nucleic acid testing requires centralized laboratories, expensive equipment, and skilled technicians, leading to delayed treatment decisions and limited antimicrobial stewardship.
Solution
eDNA Biotech delivers a portable, low‑cost nucleic acid amplification system that performs a complete sample‑to‑answer workflow at the point of need. The device integrates automated sample preparation, isothermal amplification, and real-time detection to generate reliable bacterial identification and antimicrobial‑resistance profiles within minutes. Its compact form factor and intuitive user interface enable non‑specialist operators to conduct molecular tests on‑site without external infrastructure. Results are displayed locally and can be exported via secure digital channels for electronic health‑record integration or remote expert review.
Target Audience
Primary customers are point‑of‑care laboratories, urgent‑care clinics, mobile health units, and public‑health agencies that need rapid on‑site bacterial identification and resistance profiling, especially in resource‑limited or remote settings.
Features
- Handheld, battery‑operated hardware designed for field and clinic environments
- Cartridge‑based, closed‑system workflow that automates lysis, nucleic‑acid extraction, and amplification
- Isothermal amplification technology providing rapid turnaround (≤30 min) with laboratory‑grade sensitivity
- Built‑in fluorescence detection and on‑device data processing for immediate result readout
- Pre‑loaded assay panels targeting common bacterial pathogens and key antimicrobial‑resistance genes
- Simple touchscreen UI with step‑by‑step guidance, requiring minimal training
- Secure USB/Wi‑Fi connectivity for result export and integration with EMR or public health databases
- Compliance with relevant diagnostic standards (e.g., ISO 13485, CE‑marked) for clinical use